Literature DB >> 19236815

Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide.

Xiao-ling Zhang1, Liang Wen, Yan-jiong Chen, Yi Zhu.   

Abstract

BACKGROUND: The vascular endothelial growth factor (VEGF) is involved in the initiation of retinal vascular leakage and nonperfusion in diabetes. The intracellular adhesion molecule-1 (ICAM-1) is the key mediator of the effect of VEGFs on retinal leukostasis. Although the VEGF is expressed in an early-stage diabetic retina, whether it directly up-regulates ICAM-1 in retinal endothelial cells (ECs) is unknown. In this study, we provided a new mechanism to explain that VEGF does up-regulate the expression of ICAM-1 in retinal ECs.
METHODS: Bovine retinal ECs (BRECs) were isolated and cultured. Immunohistochemical staining was performed to identify BRECs. The cultured cells were divided into corresponding groups. Then, VEGF (100 ng/ml) and other inhibitors were used to treat the cells. Cell lysate and the cultured supernatant were collected, and then, the protein level of ICAM-1 and phosphorylation of the endothelial nitric oxide synthase (eNOS) were detected using Western blotting. Griess reaction was used to detect nitric oxide (NO).
RESULTS: Western blotting showed that the VEGF up-regulated the expression of ICAM-1 protein and increased phosphorylation of the eNOS in retinal ECs. Neither the block of NO nor protein kinase C (PKC) altered the expression of ICAM-1 or the phosphorylation of eNOS. The result of the Western blotting also showed that inhibition of phosphatidylinositol 3-kinase (PI3K) or reactive oxygen species (ROS) significantly reduced the expression of ICAM-1. Inhibition of PI3K also reduced phosphorylation of eNOS. Griess reaction showed that VEGF significantly increased during NO production. When eNOS was blocked by L-NAME or PI3K was blocked by LY294002, the basal level of NO production and the increment of NO caused by VEGF could be significantly decreased.
CONCLUSION: ROS-NO coupling in the retinal endothelium may be a new mechanism that could help to explain why VEGF induces ICAM-1 expression and the resulting leukostasis in diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236815

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  15 in total

1.  Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.

Authors:  Yuan Zhu; Xiao-Ling Zhang; Bo-Feng Zhu; Yan-Ning Ding
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

2.  Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.

Authors:  Ahmed S Ibrahim; Heba Saleh; Mohamed El-Shafey; Khaled A Hussein; Khaled El-Masry; Babak Baban; Nader Sheibani; Mong-Heng Wang; Amany Tawfik; Mohamed Al-Shabrawey
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-03-27       Impact factor: 4.698

3.  Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.

Authors:  Ying Chen; Yang Hu; Ti Zhou; Kevin K Zhou; Robert Mott; Mingyuan Wu; Michael Boulton; Timothy J Lyons; Guoquan Gao; Jian-xing Ma
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

4.  Ginsenoside rg2 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell.

Authors:  Young-Suk Cho; Chan Hyung Kim; Tae-Sun Ha; Sang Jin Lee; Hee Yul Ahn
Journal:  Korean J Physiol Pharmacol       Date:  2013-04-10       Impact factor: 2.016

Review 5.  Pathophysiology of diabetic retinopathy.

Authors:  Joanna M Tarr; Kirti Kaul; Mohit Chopra; Eva M Kohner; Rakesh Chibber
Journal:  ISRN Ophthalmol       Date:  2013-01-15

6.  Regulatory SNPs Alter the Gene Expression of Diabetic Retinopathy Associated Secretary Factors.

Authors:  Chian-Feng Chen; Shiow-Wen Liou; Hsin-Han Wu; Chin-Hui Lin; Li-Shan Huang; Lin-Chung Woung; Ching-Yao Tsai
Journal:  Int J Med Sci       Date:  2016-09-12       Impact factor: 3.738

7.  Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus.

Authors:  Astha Jain; Sandeep Saxena; Vinay K Khanna; Rajendra K Shukla; Carsten H Meyer
Journal:  Mol Vis       Date:  2013-08-04       Impact factor: 2.367

8.  Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes.

Authors:  Anna Gębka; Ewelina Serkies-Minuth; Dorota Raczyńska
Journal:  Mediators Inflamm       Date:  2014-02-10       Impact factor: 4.711

9.  Effects of intravitreal injection of netrin-1 in retinal neovascularization of streptozotocin-induced diabetic rats.

Authors:  Yao Yu; Jing Zou; Yun Han; Luowa Quyang; Hui He; Peihong Hu; Yi Shao; Ping Tu
Journal:  Drug Des Devel Ther       Date:  2015-12-07       Impact factor: 4.162

10.  The Involvement of β-Catenin/COX-2/VEGF Axis in NMDA-Caused Retinopathy.

Authors:  Dan Ning; Wei Kevin Zhang; Han Tian; Xiao-Jun Li; Min Liu; Yu-Sang Li; He-Bin Tang
Journal:  J Ophthalmol       Date:  2017-10-12       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.